Neurocrine Biosciences, Inc. Financial Ratios — N1BI34 Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	94.61	4.69	-33.55	-36.79	-28.09	-38.17	-41.5	4.95	6.62	46.2	7.17	10.03	12.68	14.16	16.38
Return on Assets (%)	26.57	3.01	-26.29	-30.45	-24.78	-33.6	-24.1	2.33	3.22	26.79	4.71	6.96	8.89	9.79	11.46
Return on Capital (%)	94.61	4.69	- -	- -	- -	- -	- -	6.28	6.24	- -	6.7	8.43	10.93	15.08	14.26
Return on Invested Capital (%)	85.42	1.35	- -	- -	- -	- -	- -	4.42	5.75	- -	5.4	9.48	8.09	13.96	12.37
Gross Margin (%)	100	- -	- -	- -	100	100	99.22	98.91	99.06	99.03	98.74	98.44	97.9	98.56	98.18
EBITDA Margin (%)	44.72	3.96	-1,678.9	- -	-471.41	-972.79	-79.79	9.04	10.11	16.41	10	17.77	14.42	25.37	22.7
Operating Margin (%)	43.82	2.72	-1,701.88	- -	-476.51	-982.48	-62.71	9.22	28.75	31.31	18.33	16.73	20.92	24.75	22.25
Incremental Operating Margin (%)	108.5	133.79	101.8	504.73	- -	1,114.91	31.38	49.37	54.91	39.14	- -	11.6	36.6	40.2	10.59
Pretax Margin (%)	48.53	9.46	-1,578.97	- -	-449.84	-940.6	-88.19	4.83	5.9	10.2	8.95	14.37	17.6	20.63	24.66
Profit Margin (%)	48.53	9.46	-1,578.97	- -	-449.84	-940.6	-88.19	4.68	4.69	38.94	7.9	10.38	13.23	14.49	16.73
Net Income to Common Margin (%)	48.53	9.46	-1,578.97	- -	-449.84	-940.6	-88.19	4.68	4.69	38.94	7.9	10.38	13.23	14.49	16.73
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	3.21	20.43	- -	11.64	27.77	24.81	29.77	32.15
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	94.61	4.69	-33.55	-36.79	-28.09	-38.17	-41.5	4.95	6.62	46.2	7.17	10.03	12.68	14.16	16.38

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	370	388	496	412	440	263	428	455	415
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	409	- -	- -	169	170	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	370	388	87	412	440	94	258	455	415
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	-2.87	9.52	6.22	2.4	3.88	0.99	1.57	0.76	0.64
Net Debt/EBITDA	-1.45	-30.29	0.91	0.49	0.8	0.57	-0.89	6.05	3.72	0.76	-0.05	-0.35	-0.3	-0.39	-1.1
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	-2.81	10.56	6.85	2.53	4.3	1.06	1.71	0.8	0.67
Net Debt/EBIT	-1.48	-44.03	0.9	0.48	0.79	0.57	-0.87	6.71	4.1	0.8	-0.06	-0.38	-0.32	-0.41	-1.15
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	-6.61	1.34	2.49	5.23	4.4	37.27	59.17	4.72	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	-6.96	0.52	2.03	4.9	3.49	37.27	59.17	4.72	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	-5.19	1.36	7.08	9.98	8.05	35.07	85.83	4.61	- -
Interest Expense	- -	- -	- -	- -	- -	- -	20	31	32	33	26	7	5	127	- -
Common Equity/Total Assets	43.42	78.77	77.85	85.87	89.4	86.25	45.52	48.41	48.77	64.92	66.3	72.1	68.65	69.64	70.24
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	99.32	80.81	13.61	36.61	32.05	5.47	11.57	17.57	12.77
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	49.83	44.69	7.66	26.8	24.27	4.74	9.71	14.95	11.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	45.21	39.12	6.64	23.77	21.25	3.95	7.94	12.24	8.97
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	99.32	80.81	77.8	36.61	32.05	15.39	19.19	17.57	12.77
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	49.83	44.69	43.76	26.8	24.27	13.34	16.1	14.95	11.32
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	45.21	39.12	37.94	23.77	21.25	11.1	13.18	12.24	8.97
Net Debt to Equity	-83.4	-41.3	-37.2	-14.86	-17.48	-26.44	30.88	51.33	46.55	11.61	-0.41	-5.47	-3.63	-9	-21.92
Net Debt/Capital (%)	-502.38	-70.35	-59.23	-17.45	-21.18	-35.95	23.59	33.92	29.07	9.68	-0.39	-5.47	-3.36	-8.29	-24.13
EBITDA	35	2	-49	-64	-93	-146	-129	41	80	172	113	265	272	598	649
EBITDA-CapEx	34	1	-50	-65	-95	-150	-136	16	65	161	90	265	272	598	649
Operating Income (Loss)	34	1	-50	-64	-94	-147	-101	42	227	328	208	249	395	583	637

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.74	11.06	12.46	12.37	14.75	10.11	9.48	7.38	1.19	4.29	2.89	1.84	1.58	2.12	1.99
Current Ratio	2.81	12.1	12.69	12.65	14.94	10.21	10.2	8.36	1.47	5.45	3.96	2.7	2.45	3.4	3.39
Quick Ratio	2.78	11.96	12.46	12.37	14.75	10.11	10.05	8.03	1.41	5.14	3.65	2.49	2.25	3.06	2.92
CFO/Avg Current Liab	-0.01	-1.12	-2.17	-3.45	-1.84	-3.78	-2.22	1.42	0.45	0.61	1.19	0.87	0.65	1.02	1.25
Common Equity/Total Assets	43.42	78.77	77.85	85.87	89.4	86.25	45.52	48.41	48.77	64.92	66.3	72.1	68.65	69.64	70.24
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	99.32	80.81	13.61	36.61	32.05	5.47	11.57	17.57	12.77
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	49.83	44.69	7.66	26.8	24.27	4.74	9.71	14.95	11.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	45.21	39.12	6.64	23.77	21.25	3.95	7.94	12.24	8.97
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	99.32	80.81	77.8	36.61	32.05	15.39	19.19	17.57	12.77
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	49.83	44.69	43.76	26.8	24.27	13.34	16.1	14.95	11.32
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	45.21	39.12	37.94	23.77	21.25	11.1	13.18	12.24	8.97
CFO/Total Liabilities	-0.89	-84.83	-86.4	-137.3	-75.49	-211.48	-21.18	19.79	21.97	37.55	36.72	51.35	38.25	52.74	56.78
CFO/CapEx	-0.93	-36.35	-54.32	-29.24	-19.65	-25.85	-13.59	4.09	10	20.96	10.96	- -	- -	- -	- -
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.19	7.87	11.81	9.12	8.94	8.06

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	10.38	10.19	8.57	7.37	6.62	5.56	4.78	5.13	4.91
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	35.15	35.81	42.61	49.5	55.16	65.65	76.33	71.16	74.38
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.82	0.53	0.45	0.49	0.71	1.08	0.71	0.82
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	442.77	694.59	818.54	746.59	516.03	337.42	513.68	442.76
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.67	0.35	0.51	0.37	0.47	0.43	0.46	0.62
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	545.14	1,052.33	708.94	987.46	779.89	853.37	801.49	586.75
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-66.56	-315.13	159.1	-185.7	-198.21	-439.62	-216.64	-69.6
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-406.96	-651.97	-769.04	-691.43	-450.39	-261.09	-442.52	-368.38
Inventories	- -	- -	- -	- -	- -	- -	1	11	17	28	31	35	38	57	69
Raw Materials	- -	- -	- -	- -	- -	- -	- -	8	14	17	11	12	22	34	36
Work In Process	- -	- -	- -	- -	- -	- -	- -	2	2	2	4	6	10	11	19
Finished Goods	- -	- -	- -	- -	- -	- -	1	1	2	9	16	18	12	13	14
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	9,105	8,154	11,670	13,321	13,868	14,684
- Cash & Cash Equivalents	50	64	45	31	74	83	255	142	112	187	341	263	251	233	713
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	370	388	496	412	440	263	428	455	415
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	8,716	7,883	10,943	12,718	13,247	13,619
Total Capital	60	154	120	209	424	315	742	869	1,132	1,539	1,814	1,971	2,660	3,045	3,668
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	49.83	44.69	43.76	26.8	24.27	13.34	16.1	14.95	11.32
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.05	0.06	0.02	0.03	0.03	0.03
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.33	6.95	7.35	6.74	5.62	4.76
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.8	69.52	41.36	46.72	22.17	20.98
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	53.48	76.91	43.95	50.69	23.22	22
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.23	31.76	32.33	19.36	17.4
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.81	31.76	32.33	19.36	17.4
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	9,524	8,412	11,960	13,631	14,468	15,036
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	9,135	8,141	11,234	13,028	13,847	13,971
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.6	4.1	5.6	6.36	6.58	6.71
TTM Sales	77	53	3	- -	20	15	162	451	788	1,046	1,134	1,489	1,887	2,355	2,861
TTM EBITDA	35	2	-49	-64	-93	-146	-129	41	80	172	113	265	272	598	649
TTM Operating Income	34	1	-50	-64	-94	-147	-101	42	227	328	208	249	395	583	637
TTM Cash Flow to Firm	-1	-35	- -	- -	- -	- -	- -	131	172	- -	279	345	393	684	783
TTM Free Cash Flow to Firm	-1	-36	- -	- -	- -	- -	- -	106	158	- -	256	345	393	684	783

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	43.77	36.09	35.24	34.96	24.3	19.21
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	53.48	76.91	43.95	50.69	23.22	22
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	8,716	7,883	10,943	12,718	13,247	13,619
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.37	3.92	3.69	4.64	5.56	4.41
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.33	6.95	7.35	6.74	5.62	4.76
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.8	69.52	41.36	46.72	22.17	20.98
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.26	90.72	74.98	52.81	41.04	30.5
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.28	103.69	61.06	43.6	40.07	27.47
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.1	124.06	80.56	52.81	45.59	34.73
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	20.27	83.88	46.42	36.76	33.15	18.57
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.08	5.93	6.83	5.97	5.36	4.51
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.09	6.78	5.56	4.93	5.23	4.07
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.12	8.12	7.34	5.97	5.95	5.14
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.36	5.49	4.23	4.15	4.33	2.75
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.08	5.93	6.99	6.06	5.43	4.51
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.09	6.78	5.69	5.01	5.3	4.07
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.12	8.12	7.5	6.06	6.03	5.14
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.36	5.49	4.32	4.22	4.39	2.75
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.67	7.17	7.78	6.99	5.95	5.1
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.68	8.2	6.34	5.77	5.81	4.6
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.78	9.81	8.36	6.99	6.61	5.81
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.89	6.63	4.82	4.86	4.8	3.11
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	39.68	31.69	34.13	33.82	23.53	18.65
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	39.71	36.22	27.79	27.92	22.97	16.8
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	44.74	43.34	36.67	33.82	26.13	21.24
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	36.12	29.3	21.13	23.54	19	11.35
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	43.81	41.25	28.69	28.87	23.72	17.3
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	49.36	49.35	37.86	34.96	26.99	21.88
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	39.85	33.37	21.81	24.33	19.63	11.69
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.34	7.98	5.89	5.51	5.48	4.25
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.45	9.6	7.93	6.74	6.28	5.47
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.55	6.41	4.36	4.59	4.49	2.75
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.84	79.8	33.17	38.19	21.62	18.73
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	57.57	95.95	44.64	46.72	24.74	24.12
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.04	64.1	24.55	31.85	17.71	12.13
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	53.52	88.29	35.24	41.44	22.64	19.64
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	60.61	106.15	47.44	50.69	25.91	25.29
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.47	70.91	26.09	34.55	18.55	12.72
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.81	4.24	5.97	6.66	6.88	7.24
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.42	5.8	6.41	6.66	7.65	8.24
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	8,724	9,049	8,776	10,396	12,918	12,160
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	9,879	10,880	11,811	12,718	14,784	15,657
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	7,901	7,269	6,497	8,669	10,581	7,874

Shares Outstanding	1,120	1,347	1,365	1,550	1,748	1,761	1,799	1,840	1,870	1,895	1,923	1,956	2,000	2,014	2,029
Diluted Weighted Avg Shares	1,142	1,357	1,358	1,511	1,712	1,757	1,785	1,933	1,939	1,982	1,984	2,004	2,047	2,102	2,077
Basic Weighted Avg Shares	1,118	1,330	1,358	1,511	1,712	1,757	1,785	1,829	1,856	1,887	1,917	1,941	1,980	2,035	2,016
Revenue per Share	0.07	0.04	- -	- -	0.01	0.01	0.09	0.25	0.42	0.55	0.59	0.77	0.95	1.16	1.42
EBITDA per Share	0.03	- -	-0.04	-0.04	-0.05	-0.08	-0.07	0.02	0.04	0.09	0.06	0.14	0.14	0.29	0.32
Operating Income per Share	0.03	- -	-0.04	-0.04	-0.06	-0.08	-0.06	0.02	0.12	0.17	0.11	0.13	0.2	0.29	0.32
Basic EPS, GAAP	0.03	- -	-0.03	-0.04	-0.05	-0.08	-0.08	0.01	0.02	0.22	0.05	0.08	0.13	0.17	0.24
Basic EPS from Cont Ops	0.03	- -	-0.03	-0.04	-0.05	-0.08	-0.08	0.01	0.02	0.22	0.05	0.08	0.13	0.17	0.24
Diluted EPS, GAAP	0.03	- -	-0.03	-0.04	-0.05	-0.08	-0.08	0.01	0.02	0.21	0.05	0.08	0.12	0.16	0.23
Diluted EPS from Cont Ops	0.03	- -	-0.03	-0.04	-0.05	-0.08	-0.08	0.01	0.02	0.21	0.05	0.08	0.12	0.16	0.23
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.03	-0.02	-0.03	-0.02	-0.06	-0.05	0.06	0.08	0.12	0.13	0.17	0.2	0.29	0.39
Free Cash Flow per Basic Share	- -	-0.03	-0.02	-0.03	-0.02	-0.06	-0.06	0.04	0.07	0.12	0.12	0.17	0.2	0.29	0.39
Cash & Equivalents per Share	0.12	0.13	0.11	0.13	0.22	0.17	0.29	0.35	0.36	0.42	0.37	0.51	0.52	0.53	0.73
Book Value per Share	0.05	0.11	0.09	0.13	0.24	0.18	0.21	0.26	0.34	0.59	0.71	0.87	1.12	1.29	1.6
Tangible Book Value per Share	0.05	0.11	0.09	0.13	0.24	0.18	0.21	0.26	0.34	0.59	0.71	0.85	1.1	1.27	1.6

Neurocrine Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)